Loading clinical trials...
Loading clinical trials...
A Phase 3, Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain for Which Parenteral Opioid Therapy is Warranted
Conditions
Interventions
TRV130
Locations
10
United States
Recruiting
Mobile, Alabama, United States
Recruiting
Pasadena, California, United States
Recruiting
Miami, Florida, United States
Recruiting
Shreveport, Louisiana, United States
Recruiting
Jackson, Mississippi, United States
Staten Island, New York, United States
Start Date
December 1, 2015
Primary Completion Date
May 1, 2017
Completion Date
August 1, 2017
Last Updated
September 24, 2020
NCT07422272
NCT07310953
NCT06184126
NCT06471075
NCT06569953
NCT06853041
Lead Sponsor
Trevena Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions